Evidence map›Paper›PMID 37350639›Full record

ArticlemSystems2023

Optimizing metaproteomics database construction: lessons from a study of the vaginal microbiome.

Elliot M Lee, Sujatha Srinivasan, Samuel O Purvine, Tina L Fiedler, Owen P Leiser, Sean C Proll, Samuel S Minot, Brooke L Deatherage Kaiser, David N Fredricks

Abstract read
In one paragraph

Article in mSystems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elliot M LeeFred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA.ORCID 0000-0001-8323-2795
Sujatha SrinivasanFred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA.ORCID 0000-0002-7267-3859
Samuel O PurvinePacific Northwest National Laboratory , Richland, Washington, DC, USA.
Tina L FiedlerFred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA.
Owen P LeiserPacific Northwest National Laboratory , Richland, Washington, DC, USA.
Sean C ProllFred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA.
Samuel S MinotFred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA.
Brooke L Deatherage Kaiser *Pacific Northwest National Laboratory , Richland, Washington, DC, USA.
David N Fredricks *Fred Hutchinson Cancer Research Center , Seattle, Washington, DC, USA.ORCID 0000-0003-2735-6800

Funding

Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
The Role of Uncultivated Bacteria in Bacterial VaginosisR01AI061628 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FREDRICKS, DAVID NEAL · 2006 to 2016
$6.6M
NIAID NIH HHS R01 AI061628NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Metaproteomics, a method for untargeted, high-throughput identification of proteins in complex samples, provides functional information about microbial communities and can tie functions to specific taxa. Metaproteomics often generates less data than other omics techniques, but analytical workflows can be improved to increase usable data in metaproteomic outputs. Identification of peptides in the metaproteomic analysis is performed by comparing mass spectra of sample peptides to a reference database of protein sequences. Although these protein databases are an integral part of the metaproteomic analysis, few studies have explored how database composition impacts peptide identification. Here, we used cervicovaginal lavage (CVL) samples from a study of bacterial vaginosis (BV) to compare the performance of databases built using six different strategies. We evaluated broad versus sample-matched databases, as well as databases populated with proteins translated from metagenomic sequencing of the same samples versus sequences from public repositories. Smaller sample-matched databases performed significantly better, driven by the statistical constraints on large databases. Additionally, large databases attributed up to 34% of significant bacterial hits to taxa absent from the sample, as determined orthogonally by 16S rRNA gene sequencing. We also tested a set of hybrid databases which included bacterial proteins from NCBI RefSeq and translated bacterial genes from the samples. These hybrid databases had the best overall performance, identifying 1,068 unique human and 1,418 unique bacterial proteins, ~30% more than a database populated with proteins from typical vaginal bacteria and fungi. Our findings can help guide the optimal identification of proteins while maintaining statistical power for reaching biological conclusions. IMPORTANCE Metaproteomic analysis can provide valuable insights into the functions of microbial and cellular communities by identifying a broad, untargeted set of proteins. The databases used in the analysis of metaproteomic data influence results by defining what proteins can be identified. Moreover, the size of the database impacts the number of identifications after accounting for false discovery rates (FDRs). Few studies have tested the performance of different strategies for building a protein database to identify proteins from metaproteomic data and those that have largely focused on highly diverse microbial communities. We tested a range of databases on CVL samples and found that a hybrid sample-matched approach, using publicly available proteins from organisms present in the samples, as well as proteins translated from metagenomic sequencing of the samples, had the best performance. However, our results also suggest that public sequence databases will continue to improve as more bacterial genomes are published.

Indexed as

MicrobiotaProteomicsBacteriaBacterial ProteinsFemaleHumansPeptidesRNA, Ribosomal, 16SBacterial ProteinsPeptidesRNA, Ribosomal, 16Sdatabase optimizationmetagenomicsmetaproteomicsmicrobiomeprotein databasesproteomics

Identifiers

PMID37350639
PMCPMC10469846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.